nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—DBH—Vitamin C—prostate cancer	0.447	1	CbGbCtD
Propylthiouracil—MPO—prostate cancer	0.314	1	CbGaD
Propylthiouracil—DIO1—testis—prostate cancer	0.00414	0.275	CbGeAlD
Propylthiouracil—DBH—prostate gland—prostate cancer	0.00276	0.184	CbGeAlD
Propylthiouracil—TPO—testis—prostate cancer	0.00186	0.124	CbGeAlD
Propylthiouracil—DBH—bone marrow—prostate cancer	0.00142	0.0946	CbGeAlD
Propylthiouracil—MPO—epithelium—prostate cancer	0.00108	0.0721	CbGeAlD
Propylthiouracil—MPO—renal system—prostate cancer	0.00101	0.0669	CbGeAlD
Propylthiouracil—DBH—lymph node—prostate cancer	0.000881	0.0586	CbGeAlD
Propylthiouracil—MPO—bone marrow—prostate cancer	0.000761	0.0506	CbGeAlD
Propylthiouracil—MPO—testis—prostate cancer	0.00065	0.0433	CbGeAlD
Propylthiouracil—MPO—lymph node—prostate cancer	0.000471	0.0314	CbGeAlD
Propylthiouracil—Hepatic failure—Capecitabine—prostate cancer	0.000209	0.00191	CcSEcCtD
Propylthiouracil—Haemorrhage—Estradiol—prostate cancer	0.000208	0.00191	CcSEcCtD
Propylthiouracil—Hepatitis—Estradiol—prostate cancer	0.000208	0.00191	CcSEcCtD
Propylthiouracil—Headache—Degarelix—prostate cancer	0.000208	0.0019	CcSEcCtD
Propylthiouracil—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000207	0.0019	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—prostate cancer	0.000206	0.00188	CcSEcCtD
Propylthiouracil—Leukopenia—Goserelin—prostate cancer	0.000204	0.00187	CcSEcCtD
Propylthiouracil—Vertigo—Conjugated Estrogens—prostate cancer	0.000203	0.00186	CcSEcCtD
Propylthiouracil—Renal failure acute—Capecitabine—prostate cancer	0.000203	0.00186	CcSEcCtD
Propylthiouracil—Agranulocytosis—Mitoxantrone—prostate cancer	0.000201	0.00185	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Capecitabine—prostate cancer	0.000199	0.00182	CcSEcCtD
Propylthiouracil—Vomiting—Cabazitaxel—prostate cancer	0.000199	0.00182	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—prostate cancer	0.000198	0.00181	CcSEcCtD
Propylthiouracil—Nausea—Degarelix—prostate cancer	0.000197	0.00181	CcSEcCtD
Propylthiouracil—Headache—Cabazitaxel—prostate cancer	0.000196	0.00179	CcSEcCtD
Propylthiouracil—Haemoglobin—Mitoxantrone—prostate cancer	0.000195	0.00179	CcSEcCtD
Propylthiouracil—Myalgia—Goserelin—prostate cancer	0.000194	0.00178	CcSEcCtD
Propylthiouracil—Arthralgia—Goserelin—prostate cancer	0.000194	0.00178	CcSEcCtD
Propylthiouracil—Haemorrhage—Mitoxantrone—prostate cancer	0.000194	0.00178	CcSEcCtD
Propylthiouracil—Hepatitis—Mitoxantrone—prostate cancer	0.000194	0.00178	CcSEcCtD
Propylthiouracil—Myalgia—Conjugated Estrogens—prostate cancer	0.000193	0.00177	CcSEcCtD
Propylthiouracil—Arthralgia—Conjugated Estrogens—prostate cancer	0.000193	0.00177	CcSEcCtD
Propylthiouracil—Pruritus—Bicalutamide—prostate cancer	0.00019	0.00174	CcSEcCtD
Propylthiouracil—Oedema—Goserelin—prostate cancer	0.000186	0.00171	CcSEcCtD
Propylthiouracil—Nausea—Cabazitaxel—prostate cancer	0.000186	0.0017	CcSEcCtD
Propylthiouracil—Oedema—Conjugated Estrogens—prostate cancer	0.000185	0.00169	CcSEcCtD
Propylthiouracil—Alopecia—Estradiol—prostate cancer	0.000184	0.00169	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Goserelin—prostate cancer	0.000183	0.00167	CcSEcCtD
Propylthiouracil—Urticaria—Ethinyl Estradiol—prostate cancer	0.00018	0.00165	CcSEcCtD
Propylthiouracil—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000179	0.00164	CcSEcCtD
Propylthiouracil—Dysgeusia—Estradiol—prostate cancer	0.000177	0.00163	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Etoposide—prostate cancer	0.000176	0.00161	CcSEcCtD
Propylthiouracil—Jaundice—Etoposide—prostate cancer	0.000175	0.0016	CcSEcCtD
Propylthiouracil—Alopecia—Mitoxantrone—prostate cancer	0.000171	0.00157	CcSEcCtD
Propylthiouracil—Vomiting—Bicalutamide—prostate cancer	0.00017	0.00156	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Goserelin—prostate cancer	0.00017	0.00156	CcSEcCtD
Propylthiouracil—Rash—Bicalutamide—prostate cancer	0.000169	0.00155	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Epirubicin—prostate cancer	0.000169	0.00155	CcSEcCtD
Propylthiouracil—Dermatitis—Bicalutamide—prostate cancer	0.000169	0.00155	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000168	0.00154	CcSEcCtD
Propylthiouracil—Headache—Bicalutamide—prostate cancer	0.000168	0.00154	CcSEcCtD
Propylthiouracil—Agranulocytosis—Etoposide—prostate cancer	0.000168	0.00154	CcSEcCtD
Propylthiouracil—Paraesthesia—Goserelin—prostate cancer	0.000167	0.00153	CcSEcCtD
Propylthiouracil—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000166	0.00152	CcSEcCtD
Propylthiouracil—Somnolence—Goserelin—prostate cancer	0.000166	0.00152	CcSEcCtD
Propylthiouracil—Dysgeusia—Mitoxantrone—prostate cancer	0.000165	0.00151	CcSEcCtD
Propylthiouracil—Somnolence—Conjugated Estrogens—prostate cancer	0.000164	0.0015	CcSEcCtD
Propylthiouracil—Dyspepsia—Goserelin—prostate cancer	0.000164	0.0015	CcSEcCtD
Propylthiouracil—Vertigo—Estradiol—prostate cancer	0.000163	0.00149	CcSEcCtD
Propylthiouracil—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000163	0.00149	CcSEcCtD
Propylthiouracil—Pruritus—Ethinyl Estradiol—prostate cancer	0.00016	0.00147	CcSEcCtD
Propylthiouracil—Nausea—Bicalutamide—prostate cancer	0.000159	0.00146	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—prostate cancer	0.000156	0.00143	CcSEcCtD
Propylthiouracil—Arthralgia—Estradiol—prostate cancer	0.000154	0.00141	CcSEcCtD
Propylthiouracil—Myalgia—Estradiol—prostate cancer	0.000154	0.00141	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Epirubicin—prostate cancer	0.000153	0.0014	CcSEcCtD
Propylthiouracil—Leukopenia—Mitoxantrone—prostate cancer	0.000151	0.00138	CcSEcCtD
Propylthiouracil—Urticaria—Goserelin—prostate cancer	0.000148	0.00136	CcSEcCtD
Propylthiouracil—Oedema—Estradiol—prostate cancer	0.000148	0.00135	CcSEcCtD
Propylthiouracil—Body temperature increased—Goserelin—prostate cancer	0.000147	0.00135	CcSEcCtD
Propylthiouracil—Urticaria—Conjugated Estrogens—prostate cancer	0.000147	0.00134	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Docetaxel—prostate cancer	0.000146	0.00134	CcSEcCtD
Propylthiouracil—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000146	0.00134	CcSEcCtD
Propylthiouracil—Jaundice—Docetaxel—prostate cancer	0.000145	0.00133	CcSEcCtD
Propylthiouracil—Hepatic failure—Epirubicin—prostate cancer	0.000145	0.00133	CcSEcCtD
Propylthiouracil—Vomiting—Ethinyl Estradiol—prostate cancer	0.000144	0.00132	CcSEcCtD
Propylthiouracil—Arthralgia—Mitoxantrone—prostate cancer	0.000144	0.00132	CcSEcCtD
Propylthiouracil—Myalgia—Mitoxantrone—prostate cancer	0.000144	0.00132	CcSEcCtD
Propylthiouracil—Rash—Ethinyl Estradiol—prostate cancer	0.000143	0.00131	CcSEcCtD
Propylthiouracil—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000143	0.00131	CcSEcCtD
Propylthiouracil—Alopecia—Etoposide—prostate cancer	0.000142	0.00131	CcSEcCtD
Propylthiouracil—Headache—Ethinyl Estradiol—prostate cancer	0.000142	0.0013	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Doxorubicin—prostate cancer	0.000142	0.0013	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Capecitabine—prostate cancer	0.000142	0.0013	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—prostate cancer	0.000141	0.0013	CcSEcCtD
Propylthiouracil—Jaundice—Capecitabine—prostate cancer	0.000141	0.00129	CcSEcCtD
Propylthiouracil—Agranulocytosis—Docetaxel—prostate cancer	0.000139	0.00128	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000138	0.00127	CcSEcCtD
Propylthiouracil—Oedema—Mitoxantrone—prostate cancer	0.000138	0.00126	CcSEcCtD
Propylthiouracil—Dysgeusia—Etoposide—prostate cancer	0.000137	0.00126	CcSEcCtD
Propylthiouracil—Agranulocytosis—Capecitabine—prostate cancer	0.000135	0.00124	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000135	0.00124	CcSEcCtD
Propylthiouracil—Haemoglobin—Docetaxel—prostate cancer	0.000135	0.00123	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000135	0.00123	CcSEcCtD
Propylthiouracil—Nausea—Ethinyl Estradiol—prostate cancer	0.000135	0.00123	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—prostate cancer	0.000134	0.00123	CcSEcCtD
Propylthiouracil—Haemorrhage—Docetaxel—prostate cancer	0.000134	0.00123	CcSEcCtD
Propylthiouracil—Hepatitis—Docetaxel—prostate cancer	0.000134	0.00123	CcSEcCtD
Propylthiouracil—Paraesthesia—Estradiol—prostate cancer	0.000133	0.00122	CcSEcCtD
Propylthiouracil—Pruritus—Goserelin—prostate cancer	0.000132	0.00121	CcSEcCtD
Propylthiouracil—Somnolence—Estradiol—prostate cancer	0.000131	0.0012	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—prostate cancer	0.000131	0.0012	CcSEcCtD
Propylthiouracil—Pruritus—Conjugated Estrogens—prostate cancer	0.000131	0.0012	CcSEcCtD
Propylthiouracil—Haemoglobin—Capecitabine—prostate cancer	0.00013	0.0012	CcSEcCtD
Propylthiouracil—Dyspepsia—Estradiol—prostate cancer	0.00013	0.00119	CcSEcCtD
Propylthiouracil—Haemorrhage—Capecitabine—prostate cancer	0.00013	0.00119	CcSEcCtD
Propylthiouracil—Hepatitis—Capecitabine—prostate cancer	0.00013	0.00119	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000128	0.00117	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Prednisone—prostate cancer	0.000126	0.00116	CcSEcCtD
Propylthiouracil—Vertigo—Etoposide—prostate cancer	0.000126	0.00116	CcSEcCtD
Propylthiouracil—Leukopenia—Etoposide—prostate cancer	0.000126	0.00115	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000125	0.00115	CcSEcCtD
Propylthiouracil—Paraesthesia—Mitoxantrone—prostate cancer	0.000124	0.00113	CcSEcCtD
Propylthiouracil—Somnolence—Mitoxantrone—prostate cancer	0.000122	0.00112	CcSEcCtD
Propylthiouracil—Dyspepsia—Mitoxantrone—prostate cancer	0.000121	0.00111	CcSEcCtD
Propylthiouracil—Vomiting—Goserelin—prostate cancer	0.000119	0.00109	CcSEcCtD
Propylthiouracil—Alopecia—Docetaxel—prostate cancer	0.000118	0.00109	CcSEcCtD
Propylthiouracil—Rash—Goserelin—prostate cancer	0.000118	0.00108	CcSEcCtD
Propylthiouracil—Dermatitis—Goserelin—prostate cancer	0.000117	0.00108	CcSEcCtD
Propylthiouracil—Vomiting—Conjugated Estrogens—prostate cancer	0.000117	0.00108	CcSEcCtD
Propylthiouracil—Urticaria—Estradiol—prostate cancer	0.000117	0.00108	CcSEcCtD
Propylthiouracil—Body temperature increased—Estradiol—prostate cancer	0.000117	0.00107	CcSEcCtD
Propylthiouracil—Headache—Goserelin—prostate cancer	0.000117	0.00107	CcSEcCtD
Propylthiouracil—Rash—Conjugated Estrogens—prostate cancer	0.000116	0.00107	CcSEcCtD
Propylthiouracil—Dermatitis—Conjugated Estrogens—prostate cancer	0.000116	0.00107	CcSEcCtD
Propylthiouracil—Haemoglobin—Prednisone—prostate cancer	0.000116	0.00106	CcSEcCtD
Propylthiouracil—Headache—Conjugated Estrogens—prostate cancer	0.000116	0.00106	CcSEcCtD
Propylthiouracil—Haemorrhage—Prednisone—prostate cancer	0.000116	0.00106	CcSEcCtD
Propylthiouracil—Alopecia—Capecitabine—prostate cancer	0.000115	0.00105	CcSEcCtD
Propylthiouracil—Dysgeusia—Docetaxel—prostate cancer	0.000114	0.00105	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Etoposide—prostate cancer	0.000112	0.00103	CcSEcCtD
Propylthiouracil—Nausea—Goserelin—prostate cancer	0.000111	0.00102	CcSEcCtD
Propylthiouracil—Dysgeusia—Capecitabine—prostate cancer	0.000111	0.00101	CcSEcCtD
Propylthiouracil—Nausea—Conjugated Estrogens—prostate cancer	0.00011	0.00101	CcSEcCtD
Propylthiouracil—Urticaria—Mitoxantrone—prostate cancer	0.000109	0.001	CcSEcCtD
Propylthiouracil—Body temperature increased—Mitoxantrone—prostate cancer	0.000109	0.000998	CcSEcCtD
Propylthiouracil—Pruritus—Estradiol—prostate cancer	0.000105	0.000958	CcSEcCtD
Propylthiouracil—Leukopenia—Docetaxel—prostate cancer	0.000104	0.000957	CcSEcCtD
Propylthiouracil—Paraesthesia—Etoposide—prostate cancer	0.000103	0.000943	CcSEcCtD
Propylthiouracil—Alopecia—Prednisone—prostate cancer	0.000102	0.000936	CcSEcCtD
Propylthiouracil—Somnolence—Etoposide—prostate cancer	0.000102	0.000933	CcSEcCtD
Propylthiouracil—Vertigo—Capecitabine—prostate cancer	0.000101	0.00093	CcSEcCtD
Propylthiouracil—Leukopenia—Capecitabine—prostate cancer	0.000101	0.000927	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—prostate cancer	0.000101	0.000923	CcSEcCtD
Propylthiouracil—Arthralgia—Docetaxel—prostate cancer	9.93e-05	0.00091	CcSEcCtD
Propylthiouracil—Myalgia—Docetaxel—prostate cancer	9.93e-05	0.00091	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—prostate cancer	9.87e-05	0.000905	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—prostate cancer	9.81e-05	0.0009	CcSEcCtD
Propylthiouracil—Myalgia—Capecitabine—prostate cancer	9.61e-05	0.000881	CcSEcCtD
Propylthiouracil—Arthralgia—Capecitabine—prostate cancer	9.61e-05	0.000881	CcSEcCtD
Propylthiouracil—Oedema—Docetaxel—prostate cancer	9.52e-05	0.000873	CcSEcCtD
Propylthiouracil—Vomiting—Estradiol—prostate cancer	9.4e-05	0.000861	CcSEcCtD
Propylthiouracil—Agranulocytosis—Epirubicin—prostate cancer	9.39e-05	0.000861	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Docetaxel—prostate cancer	9.32e-05	0.000854	CcSEcCtD
Propylthiouracil—Rash—Estradiol—prostate cancer	9.32e-05	0.000854	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—prostate cancer	9.31e-05	0.000854	CcSEcCtD
Propylthiouracil—Dermatitis—Estradiol—prostate cancer	9.31e-05	0.000853	CcSEcCtD
Propylthiouracil—Headache—Estradiol—prostate cancer	9.26e-05	0.000849	CcSEcCtD
Propylthiouracil—Oedema—Capecitabine—prostate cancer	9.22e-05	0.000845	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—prostate cancer	9.13e-05	0.000837	CcSEcCtD
Propylthiouracil—Urticaria—Etoposide—prostate cancer	9.1e-05	0.000834	CcSEcCtD
Propylthiouracil—Haemoglobin—Epirubicin—prostate cancer	9.08e-05	0.000833	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—prostate cancer	9.08e-05	0.000832	CcSEcCtD
Propylthiouracil—Body temperature increased—Etoposide—prostate cancer	9.05e-05	0.00083	CcSEcCtD
Propylthiouracil—Vertigo—Prednisone—prostate cancer	9.04e-05	0.000828	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—prostate cancer	9.04e-05	0.000828	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—prostate cancer	9.04e-05	0.000828	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Capecitabine—prostate cancer	9.02e-05	0.000827	CcSEcCtD
Propylthiouracil—Nausea—Estradiol—prostate cancer	8.78e-05	0.000805	CcSEcCtD
Propylthiouracil—Vomiting—Mitoxantrone—prostate cancer	8.76e-05	0.000803	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—prostate cancer	8.69e-05	0.000797	CcSEcCtD
Propylthiouracil—Rash—Mitoxantrone—prostate cancer	8.68e-05	0.000796	CcSEcCtD
Propylthiouracil—Dermatitis—Mitoxantrone—prostate cancer	8.67e-05	0.000795	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.67e-05	0.000795	CcSEcCtD
Propylthiouracil—Headache—Mitoxantrone—prostate cancer	8.63e-05	0.000791	CcSEcCtD
Propylthiouracil—Myalgia—Prednisone—prostate cancer	8.56e-05	0.000785	CcSEcCtD
Propylthiouracil—Arthralgia—Prednisone—prostate cancer	8.56e-05	0.000785	CcSEcCtD
Propylthiouracil—Paraesthesia—Docetaxel—prostate cancer	8.55e-05	0.000784	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP3A43—prostate cancer	8.48e-05	0.000739	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AMACR—prostate cancer	8.48e-05	0.000739	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NAT1—prostate cancer	8.48e-05	0.000739	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—DEGS1—prostate cancer	8.48e-05	0.000739	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SRD5A2—prostate cancer	8.48e-05	0.000739	CbGpPWpGaD
Propylthiouracil—Somnolence—Docetaxel—prostate cancer	8.46e-05	0.000776	CcSEcCtD
Propylthiouracil—TPO—Metabolism—AOX1—prostate cancer	8.41e-05	0.000733	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MBTPS1—prostate cancer	8.41e-05	0.000733	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTM3—prostate cancer	8.41e-05	0.000733	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—RFK—prostate cancer	8.41e-05	0.000733	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SULT2B1—prostate cancer	8.41e-05	0.000733	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NAGLU—prostate cancer	8.41e-05	0.000733	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PGAM2—prostate cancer	8.41e-05	0.000733	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Doxorubicin—prostate cancer	8.4e-05	0.00077	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.4e-05	0.00077	CcSEcCtD
Propylthiouracil—Dyspepsia—Docetaxel—prostate cancer	8.38e-05	0.000768	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—prostate cancer	8.36e-05	0.000767	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—prostate cancer	8.36e-05	0.000767	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—BCL2—prostate cancer	8.33e-05	0.000726	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL6—prostate cancer	8.31e-05	0.000724	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Capecitabine—prostate cancer	8.28e-05	0.000759	CcSEcCtD
Propylthiouracil—Oedema—Prednisone—prostate cancer	8.21e-05	0.000753	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—TBXAS1—prostate cancer	8.18e-05	0.000713	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTA4—prostate cancer	8.18e-05	0.000713	CbGpPWpGaD
Propylthiouracil—Nausea—Mitoxantrone—prostate cancer	8.18e-05	0.00075	CcSEcCtD
Propylthiouracil—Dyspepsia—Capecitabine—prostate cancer	8.11e-05	0.000744	CcSEcCtD
Propylthiouracil—Pruritus—Etoposide—prostate cancer	8.1e-05	0.000743	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HSD17B1—prostate cancer	8.09e-05	0.000705	CbGpPWpGaD
Propylthiouracil—Alopecia—Epirubicin—prostate cancer	7.99e-05	0.000732	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA2—prostate cancer	7.97e-05	0.000695	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP3A43—prostate cancer	7.97e-05	0.000695	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AMACR—prostate cancer	7.97e-05	0.000695	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NAT1—prostate cancer	7.97e-05	0.000695	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—DEGS1—prostate cancer	7.97e-05	0.000695	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SRD5A2—prostate cancer	7.97e-05	0.000695	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—PTGS2—prostate cancer	7.91e-05	0.000689	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SULT1A1—prostate cancer	7.88e-05	0.000686	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ABCG5—prostate cancer	7.88e-05	0.000686	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Epirubicin—prostate cancer	7.7e-05	0.000706	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA1—prostate cancer	7.69e-05	0.00067	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—PTGS2—prostate cancer	7.62e-05	0.000664	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTO1—prostate cancer	7.61e-05	0.000663	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HSD3B2—prostate cancer	7.61e-05	0.000663	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HSD17B1—prostate cancer	7.61e-05	0.000663	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NAT2—prostate cancer	7.61e-05	0.000663	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Docetaxel—prostate cancer	7.52e-05	0.00069	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1B—prostate cancer	7.49e-05	0.000653	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Prednisone—prostate cancer	7.48e-05	0.000686	CcSEcCtD
Propylthiouracil—Alopecia—Doxorubicin—prostate cancer	7.39e-05	0.000677	CcSEcCtD
Propylthiouracil—Paraesthesia—Prednisone—prostate cancer	7.37e-05	0.000676	CcSEcCtD
Propylthiouracil—Urticaria—Capecitabine—prostate cancer	7.32e-05	0.000671	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PLCB2—prostate cancer	7.29e-05	0.000636	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—LRP2—prostate cancer	7.29e-05	0.000636	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP2C18—prostate cancer	7.29e-05	0.000636	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Capecitabine—prostate cancer	7.29e-05	0.000668	CcSEcCtD
Propylthiouracil—Vomiting—Etoposide—prostate cancer	7.28e-05	0.000668	CcSEcCtD
Propylthiouracil—Dyspepsia—Prednisone—prostate cancer	7.23e-05	0.000662	CcSEcCtD
Propylthiouracil—Rash—Etoposide—prostate cancer	7.22e-05	0.000662	CcSEcCtD
Propylthiouracil—Dermatitis—Etoposide—prostate cancer	7.22e-05	0.000661	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HPGD—prostate cancer	7.21e-05	0.000628	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—B4GALT4—prostate cancer	7.21e-05	0.000628	CbGpPWpGaD
Propylthiouracil—Headache—Etoposide—prostate cancer	7.18e-05	0.000658	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—P4HB—prostate cancer	7.15e-05	0.000623	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—prostate cancer	7.15e-05	0.000623	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Doxorubicin—prostate cancer	7.13e-05	0.000653	CcSEcCtD
Propylthiouracil—Vertigo—Epirubicin—prostate cancer	7.07e-05	0.000648	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—prostate cancer	7.04e-05	0.000646	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SLC22A1—prostate cancer	6.96e-05	0.000606	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1A—prostate cancer	6.92e-05	0.000603	CbGpPWpGaD
Propylthiouracil—Nausea—Etoposide—prostate cancer	6.8e-05	0.000624	CcSEcCtD
Propylthiouracil—DBH—Metabolism—TNFRSF21—prostate cancer	6.78e-05	0.000591	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HPGD—prostate cancer	6.78e-05	0.000591	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SULT2A1—prostate cancer	6.78e-05	0.000591	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—B4GALT4—prostate cancer	6.78e-05	0.000591	CbGpPWpGaD
Propylthiouracil—Pruritus—Docetaxel—prostate cancer	6.73e-05	0.000617	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—prostate cancer	6.7e-05	0.000614	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—prostate cancer	6.7e-05	0.000614	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—MED12—prostate cancer	6.67e-05	0.000581	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GNG5—prostate cancer	6.62e-05	0.000577	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTAP—prostate cancer	6.6e-05	0.000575	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP7B1—prostate cancer	6.6e-05	0.000575	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—EP300—prostate cancer	6.58e-05	0.000573	CbGpPWpGaD
Propylthiouracil—Vertigo—Doxorubicin—prostate cancer	6.54e-05	0.0006	CcSEcCtD
Propylthiouracil—Urticaria—Prednisone—prostate cancer	6.52e-05	0.000598	CcSEcCtD
Propylthiouracil—Pruritus—Capecitabine—prostate cancer	6.52e-05	0.000598	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—prostate cancer	6.52e-05	0.000597	CcSEcCtD
Propylthiouracil—Body temperature increased—Prednisone—prostate cancer	6.49e-05	0.000595	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SULT1E1—prostate cancer	6.43e-05	0.00056	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SRD5A1—prostate cancer	6.43e-05	0.00056	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL6—prostate cancer	6.42e-05	0.00056	CbGpPWpGaD
Propylthiouracil—Oedema—Epirubicin—prostate cancer	6.42e-05	0.000589	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NCOA3—prostate cancer	6.37e-05	0.000556	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TNFRSF21—prostate cancer	6.37e-05	0.000556	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Epirubicin—prostate cancer	6.29e-05	0.000576	CcSEcCtD
Propylthiouracil—TPO—Metabolism—MTAP—prostate cancer	6.2e-05	0.00054	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP7B1—prostate cancer	6.2e-05	0.00054	CbGpPWpGaD
Propylthiouracil—Myalgia—Doxorubicin—prostate cancer	6.2e-05	0.000568	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—prostate cancer	6.2e-05	0.000568	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HSD17B3—prostate cancer	6.13e-05	0.000534	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ACSL4—prostate cancer	6.13e-05	0.000534	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HPGDS—prostate cancer	6.08e-05	0.00053	CbGpPWpGaD
Propylthiouracil—Vomiting—Docetaxel—prostate cancer	6.05e-05	0.000555	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP2C19—prostate cancer	6.04e-05	0.000527	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SULT1E1—prostate cancer	6.04e-05	0.000527	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SRD5A1—prostate cancer	6.04e-05	0.000527	CbGpPWpGaD
Propylthiouracil—Rash—Docetaxel—prostate cancer	6e-05	0.00055	CcSEcCtD
Propylthiouracil—Dermatitis—Docetaxel—prostate cancer	6e-05	0.00055	CcSEcCtD
Propylthiouracil—Headache—Docetaxel—prostate cancer	5.96e-05	0.000547	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—prostate cancer	5.94e-05	0.000545	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTT1—prostate cancer	5.9e-05	0.000514	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ACHE—prostate cancer	5.9e-05	0.000514	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PHGDH—prostate cancer	5.88e-05	0.000512	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—UMPS—prostate cancer	5.88e-05	0.000512	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ARG2—prostate cancer	5.88e-05	0.000512	CbGpPWpGaD
Propylthiouracil—Vomiting—Capecitabine—prostate cancer	5.86e-05	0.000537	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.85e-05	0.000536	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP2A6—prostate cancer	5.83e-05	0.000508	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Doxorubicin—prostate cancer	5.82e-05	0.000533	CcSEcCtD
Propylthiouracil—Rash—Capecitabine—prostate cancer	5.81e-05	0.000533	CcSEcCtD
Propylthiouracil—Pruritus—Prednisone—prostate cancer	5.81e-05	0.000532	CcSEcCtD
Propylthiouracil—Dermatitis—Capecitabine—prostate cancer	5.81e-05	0.000532	CcSEcCtD
Propylthiouracil—Headache—Capecitabine—prostate cancer	5.77e-05	0.000529	CcSEcCtD
Propylthiouracil—Paraesthesia—Epirubicin—prostate cancer	5.77e-05	0.000529	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ACSL4—prostate cancer	5.77e-05	0.000502	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HSD17B3—prostate cancer	5.77e-05	0.000502	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—LDHB—prostate cancer	5.77e-05	0.000502	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—prostate cancer	5.73e-05	0.0005	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—prostate cancer	5.71e-05	0.000498	CbGpPWpGaD
Propylthiouracil—Somnolence—Epirubicin—prostate cancer	5.71e-05	0.000523	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—AKR1C3—prostate cancer	5.67e-05	0.000494	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP3A5—prostate cancer	5.66e-05	0.000493	CbGpPWpGaD
Propylthiouracil—Nausea—Docetaxel—prostate cancer	5.65e-05	0.000518	CcSEcCtD
Propylthiouracil—Dyspepsia—Epirubicin—prostate cancer	5.65e-05	0.000518	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PRKACB—prostate cancer	5.64e-05	0.000492	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP17A1—prostate cancer	5.58e-05	0.000487	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—UMPS—prostate cancer	5.53e-05	0.000482	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ARG2—prostate cancer	5.53e-05	0.000482	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PHGDH—prostate cancer	5.53e-05	0.000482	CbGpPWpGaD
Propylthiouracil—Nausea—Capecitabine—prostate cancer	5.47e-05	0.000502	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PDHA1—prostate cancer	5.47e-05	0.000476	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TCN2—prostate cancer	5.47e-05	0.000476	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—UCP3—prostate cancer	5.47e-05	0.000476	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA3—prostate cancer	5.47e-05	0.000476	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—LDHB—prostate cancer	5.42e-05	0.000472	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.41e-05	0.000496	CcSEcCtD
Propylthiouracil—Paraesthesia—Doxorubicin—prostate cancer	5.33e-05	0.000489	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NCOA2—prostate cancer	5.32e-05	0.000464	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP3A5—prostate cancer	5.32e-05	0.000464	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—prostate cancer	5.3e-05	0.000462	CbGpPWpGaD
Propylthiouracil—Somnolence—Doxorubicin—prostate cancer	5.28e-05	0.000484	CcSEcCtD
Propylthiouracil—Dyspepsia—Doxorubicin—prostate cancer	5.23e-05	0.000479	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IL6—prostate cancer	5.23e-05	0.000456	CbGpPWpGaD
Propylthiouracil—Vomiting—Prednisone—prostate cancer	5.22e-05	0.000478	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HSD3B1—prostate cancer	5.21e-05	0.000454	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC22A3—prostate cancer	5.21e-05	0.000454	CbGpPWpGaD
Propylthiouracil—Rash—Prednisone—prostate cancer	5.18e-05	0.000474	CcSEcCtD
Propylthiouracil—Dermatitis—Prednisone—prostate cancer	5.17e-05	0.000474	CcSEcCtD
Propylthiouracil—Headache—Prednisone—prostate cancer	5.14e-05	0.000471	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PDHA1—prostate cancer	5.14e-05	0.000448	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TCN2—prostate cancer	5.14e-05	0.000448	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—UCP3—prostate cancer	5.14e-05	0.000448	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA3—prostate cancer	5.14e-05	0.000448	CbGpPWpGaD
Propylthiouracil—Urticaria—Epirubicin—prostate cancer	5.1e-05	0.000468	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SLC5A5—prostate cancer	5.08e-05	0.000442	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Epirubicin—prostate cancer	5.08e-05	0.000465	CcSEcCtD
Propylthiouracil—DBH—Metabolism—TBXAS1—prostate cancer	5e-05	0.000436	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA4—prostate cancer	5e-05	0.000436	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP2E1—prostate cancer	4.96e-05	0.000432	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NQO1—prostate cancer	4.9e-05	0.000427	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HSD3B1—prostate cancer	4.9e-05	0.000427	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC22A3—prostate cancer	4.9e-05	0.000427	CbGpPWpGaD
Propylthiouracil—Nausea—Prednisone—prostate cancer	4.88e-05	0.000447	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTA2—prostate cancer	4.87e-05	0.000425	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—TH—prostate cancer	4.83e-05	0.000421	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SULT1A1—prostate cancer	4.81e-05	0.000419	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCG5—prostate cancer	4.81e-05	0.000419	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP3A4—prostate cancer	4.78e-05	0.000417	CbGpPWpGaD
Propylthiouracil—Urticaria—Doxorubicin—prostate cancer	4.72e-05	0.000433	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP1B1—prostate cancer	4.7e-05	0.00041	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TBXAS1—prostate cancer	4.7e-05	0.00041	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA1—prostate cancer	4.7e-05	0.00041	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA4—prostate cancer	4.7e-05	0.00041	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Doxorubicin—prostate cancer	4.7e-05	0.000431	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTO1—prostate cancer	4.65e-05	0.000405	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HSD3B2—prostate cancer	4.65e-05	0.000405	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NAT2—prostate cancer	4.65e-05	0.000405	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA2—prostate cancer	4.58e-05	0.000399	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GGT1—prostate cancer	4.55e-05	0.000397	CbGpPWpGaD
Propylthiouracil—Pruritus—Epirubicin—prostate cancer	4.54e-05	0.000416	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SULT1A1—prostate cancer	4.52e-05	0.000394	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCG5—prostate cancer	4.52e-05	0.000394	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NCOA1—prostate cancer	4.48e-05	0.000391	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PLCB2—prostate cancer	4.46e-05	0.000388	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—LRP2—prostate cancer	4.46e-05	0.000388	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP2C18—prostate cancer	4.46e-05	0.000388	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP19A1—prostate cancer	4.42e-05	0.000385	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA1—prostate cancer	4.42e-05	0.000385	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HSD3B2—prostate cancer	4.37e-05	0.000381	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTO1—prostate cancer	4.37e-05	0.000381	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NAT2—prostate cancer	4.37e-05	0.000381	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—P4HB—prostate cancer	4.37e-05	0.000381	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—RXRA—prostate cancer	4.26e-05	0.000372	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC22A1—prostate cancer	4.25e-05	0.00037	CbGpPWpGaD
Propylthiouracil—Pruritus—Doxorubicin—prostate cancer	4.2e-05	0.000385	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PLCB2—prostate cancer	4.19e-05	0.000365	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—LRP2—prostate cancer	4.19e-05	0.000365	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2C18—prostate cancer	4.19e-05	0.000365	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL6—prostate cancer	4.15e-05	0.000362	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SULT2A1—prostate cancer	4.14e-05	0.000361	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—COMT—prostate cancer	4.11e-05	0.000358	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—P4HB—prostate cancer	4.11e-05	0.000358	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTP1—prostate cancer	4.09e-05	0.000356	CbGpPWpGaD
Propylthiouracil—Vomiting—Epirubicin—prostate cancer	4.08e-05	0.000374	CcSEcCtD
Propylthiouracil—DBH—Metabolism—MED12—prostate cancer	4.07e-05	0.000355	CbGpPWpGaD
Propylthiouracil—Rash—Epirubicin—prostate cancer	4.05e-05	0.000371	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—prostate cancer	4.04e-05	0.000371	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GNG5—prostate cancer	4.04e-05	0.000352	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ITPR1—prostate cancer	4.02e-05	0.000351	CbGpPWpGaD
Propylthiouracil—Headache—Epirubicin—prostate cancer	4.02e-05	0.000369	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SLC22A1—prostate cancer	4e-05	0.000348	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOA3—prostate cancer	3.89e-05	0.000339	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SULT2A1—prostate cancer	3.89e-05	0.000339	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MED12—prostate cancer	3.83e-05	0.000334	CbGpPWpGaD
Propylthiouracil—Nausea—Epirubicin—prostate cancer	3.81e-05	0.00035	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—TYMS—prostate cancer	3.8e-05	0.000331	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GNG5—prostate cancer	3.8e-05	0.000331	CbGpPWpGaD
Propylthiouracil—Vomiting—Doxorubicin—prostate cancer	3.78e-05	0.000346	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTM1—prostate cancer	3.76e-05	0.000327	CbGpPWpGaD
Propylthiouracil—Rash—Doxorubicin—prostate cancer	3.75e-05	0.000343	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—prostate cancer	3.74e-05	0.000343	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—prostate cancer	3.72e-05	0.000341	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HPGDS—prostate cancer	3.71e-05	0.000324	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP2C19—prostate cancer	3.69e-05	0.000322	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—LPL—prostate cancer	3.69e-05	0.000321	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOA3—prostate cancer	3.66e-05	0.000319	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTT1—prostate cancer	3.6e-05	0.000314	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ACHE—prostate cancer	3.6e-05	0.000314	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP1A1—prostate cancer	3.56e-05	0.00031	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP2A6—prostate cancer	3.56e-05	0.00031	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ERCC2—prostate cancer	3.53e-05	0.000308	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—prostate cancer	3.53e-05	0.000323	CcSEcCtD
Propylthiouracil—TPO—Metabolism—HPGDS—prostate cancer	3.49e-05	0.000304	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2C19—prostate cancer	3.47e-05	0.000302	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKR1C3—prostate cancer	3.46e-05	0.000302	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PRKACB—prostate cancer	3.45e-05	0.0003	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP17A1—prostate cancer	3.41e-05	0.000297	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ACHE—prostate cancer	3.39e-05	0.000295	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTT1—prostate cancer	3.39e-05	0.000295	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2A6—prostate cancer	3.35e-05	0.000292	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—MTHFR—prostate cancer	3.32e-05	0.000289	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PPARA—prostate cancer	3.26e-05	0.000284	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKR1C3—prostate cancer	3.26e-05	0.000284	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOA2—prostate cancer	3.25e-05	0.000283	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PRKACB—prostate cancer	3.24e-05	0.000282	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP17A1—prostate cancer	3.21e-05	0.000279	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC5A5—prostate cancer	3.1e-05	0.00027	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CAV1—prostate cancer	3.06e-05	0.000267	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOA2—prostate cancer	3.06e-05	0.000266	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP2E1—prostate cancer	3.03e-05	0.000264	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NQO1—prostate cancer	2.99e-05	0.000261	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TH—prostate cancer	2.95e-05	0.000257	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP3A4—prostate cancer	2.92e-05	0.000254	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC5A5—prostate cancer	2.92e-05	0.000254	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP1B1—prostate cancer	2.87e-05	0.00025	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2E1—prostate cancer	2.85e-05	0.000248	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NQO1—prostate cancer	2.82e-05	0.000245	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CG—prostate cancer	2.79e-05	0.000243	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GGT1—prostate cancer	2.78e-05	0.000242	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TH—prostate cancer	2.77e-05	0.000242	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP3A4—prostate cancer	2.75e-05	0.000239	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOA1—prostate cancer	2.74e-05	0.000239	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP19A1—prostate cancer	2.7e-05	0.000235	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1B1—prostate cancer	2.7e-05	0.000235	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—INS—prostate cancer	2.64e-05	0.00023	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GGT1—prostate cancer	2.61e-05	0.000228	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—RXRA—prostate cancer	2.61e-05	0.000227	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CREBBP—prostate cancer	2.59e-05	0.000225	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOA1—prostate cancer	2.58e-05	0.000224	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP19A1—prostate cancer	2.54e-05	0.000221	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—COMT—prostate cancer	2.51e-05	0.000219	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTP1—prostate cancer	2.5e-05	0.000218	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ITPR1—prostate cancer	2.46e-05	0.000214	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CD—prostate cancer	2.45e-05	0.000214	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—RXRA—prostate cancer	2.45e-05	0.000213	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—COMT—prostate cancer	2.36e-05	0.000206	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTP1—prostate cancer	2.35e-05	0.000205	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TYMS—prostate cancer	2.32e-05	0.000202	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NOS3—prostate cancer	2.32e-05	0.000202	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ITPR1—prostate cancer	2.31e-05	0.000201	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTM1—prostate cancer	2.3e-05	0.0002	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—LPL—prostate cancer	2.25e-05	0.000196	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TYMS—prostate cancer	2.18e-05	0.00019	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP1A1—prostate cancer	2.18e-05	0.00019	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ERCC2—prostate cancer	2.16e-05	0.000188	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTM1—prostate cancer	2.16e-05	0.000188	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—prostate cancer	2.14e-05	0.000186	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTGS2—prostate cancer	2.12e-05	0.000185	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—LPL—prostate cancer	2.12e-05	0.000185	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1A1—prostate cancer	2.05e-05	0.000178	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ERCC2—prostate cancer	2.03e-05	0.000177	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTHFR—prostate cancer	2.03e-05	0.000177	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PPARA—prostate cancer	1.99e-05	0.000173	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTHFR—prostate cancer	1.91e-05	0.000166	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CAV1—prostate cancer	1.87e-05	0.000163	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PPARA—prostate cancer	1.87e-05	0.000163	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTEN—prostate cancer	1.85e-05	0.000161	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—EP300—prostate cancer	1.76e-05	0.000154	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CAV1—prostate cancer	1.76e-05	0.000153	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CG—prostate cancer	1.7e-05	0.000149	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—INS—prostate cancer	1.61e-05	0.000141	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CG—prostate cancer	1.6e-05	0.00014	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CREBBP—prostate cancer	1.58e-05	0.000138	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—INS—prostate cancer	1.52e-05	0.000132	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—prostate cancer	1.5e-05	0.000131	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CREBBP—prostate cancer	1.49e-05	0.000129	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NOS3—prostate cancer	1.41e-05	0.000123	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—prostate cancer	1.41e-05	0.000123	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NOS3—prostate cancer	1.33e-05	0.000116	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—prostate cancer	1.31e-05	0.000114	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—prostate cancer	1.3e-05	0.000114	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTGS2—prostate cancer	1.29e-05	0.000113	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—prostate cancer	1.23e-05	0.000107	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS2—prostate cancer	1.22e-05	0.000106	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—prostate cancer	1.13e-05	9.83e-05	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—EP300—prostate cancer	1.08e-05	9.38e-05	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—prostate cancer	1.06e-05	9.28e-05	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—prostate cancer	1.06e-05	9.25e-05	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—EP300—prostate cancer	1.01e-05	8.82e-05	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—prostate cancer	7.96e-06	6.94e-05	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—prostate cancer	7.48e-06	6.52e-05	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—prostate cancer	6.5e-06	5.67e-05	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—prostate cancer	6.11e-06	5.33e-05	CbGpPWpGaD
